Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract CT032: Adoptive T cell transfer combined with DC vaccination in patients with metastatic melanoma

stina L. wickström, Tanja Lövgren, Maria Wolodarski, Ulrika Edbäck, Eva Martell, Karin Markland, Maria Nyström, Andreas Lundqvist, Hans Jacobsson, Johan Hansson, Giuseppe Masucci, Roger Tell, Isabel Poschke, Lars Adamson, Jonas Mattsson, Rolf Kiessling

Cancer Res (2018) 78 (13_Supplement): CT032.

DOI: https://doi.org/10.1158/1538-7445.AM2018-CT032

Published: 01 July 2018

View article

Journal Articles

Melanoma-Educated CD14⁺ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms

Yumeng Mao, Isabel Poschke, Erik Wennerberg, Yago Pico de Coaña, Suzanne Egyhazi Brage, Inkeri Schultz, Johan Hansson, Giuseppe Masucci, Andreas Lundqvist, Rolf Kiessling

Cancer Res (2013) 73 (13): 3877–3887.

DOI: https://doi.org/10.1158/0008-5472.CAN-12-4115

Published: 30 June 2013

View article

Includes: Supplementary data

Journal Articles

A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins

Elena Quaglino, Cristina Mastini, Augusto Amici, Cristina Marchini, Manuela Iezzi, Stefania Lanzardo, Carla De Giovanni, Maura Montani, Pier-Luigi Lollini, Giuseppe Masucci, Guido Forni, Federica Cavallo

Cancer Res (2010) 70 (7): 2604–2612.

DOI: https://doi.org/10.1158/0008-5472.CAN-09-2548

Published: 31 March 2010

View article

Includes: Supplementary data

Journal Articles

Frequent Loss of HLA-A2 Expression in Metastasizing Ovarian Carcinomas Associated with Genomic Haplotype Loss and HLA-A2-Restricted HER-2/neu-Specific Immunity

Håkan Norell, Mattias Carlsten, Tomas Ohlum, Karl-Johan Malmberg, Giuseppe Masucci, Kjell Schedvins, Wolfgang Altermann, Diana Handke, Derek Atkins, Barbara Seliger, Rolf Kiessling

Cancer Res (2006) 66 (12): 6387–6394.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-0029

Published: 15 June 2006

View article

Journal Articles

Synthetic Peptides Derived from the Melanocyte-stimulating Hormone Receptor MC1R Can Stimulate HLA-A2-restricted Cytotoxic T Lymphocytes That Recognize Naturally Processed Peptides on Human Melanoma Cells

Flavio Salazar-Onfray, Tsutomu Nakazawa, Vijay Chhajlani, Max Petersson, Klas Kärre, Giuseppe Masucci, Esteban Celis, Alessandro Sette, Scott Southwood, Ettore Appella, Rolf Kiessling

Cancer Res (1997) 57 (19): 4348–4355.

Published: 01 October 1997

View article

Journal Articles

Immunological Characterization of Hodgkin's and Non-Hodgkin's Lymphoma Patients with High Antibody Titers against Epstein-Barr Virus-associated Antigens

Giuseppe Masucci, Håkan Mellstedt, Maria G. Masucci, Robert Szigeti, Ingemar Emberg, Magnus Björkholm, Koji Tsukuda, Gertrude Henle, Werner Henle, Gary Pearson, Göran Holm, Peter Biberfeld, Bo Johansson, George Klein

Cancer Res (1984) 44 (3): 1288–1300.

Published: 01 March 1984

View article

Journal Articles

Cell-mediated Immune Reactions in Three Patients with Malignant Lymphoproliferative Diseases in Remission and Abnormally High Epstein-Barr Virus Antibody Titers

Maria Grazia Masucci, Robert Szigeti, Ingemar Ernberg, Magnus Björkholm, Håkan Mellstedt, Gertrude Henle, Werner Henle, Gary Pearson, Giuseppe Masucci, Erik Svedmyr, Bo Johansson, George Klein

Cancer Res (1981) 41 (11_Part_1): 4292–4301.

Published: 01 November 1981

View article

NARROW

Abstract CT032: Adoptive T cell transfer combined with DC vaccination in patients with metastatic melanoma

Melanoma-Educated CD14⁺ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms

A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins

Frequent Loss of HLA-A2 Expression in Metastasizing Ovarian Carcinomas Associated with Genomic Haplotype Loss and HLA-A2-Restricted HER-2/neu-Specific Immunity

Synthetic Peptides Derived from the Melanocyte-stimulating Hormone Receptor MC1R Can Stimulate HLA-A2-restricted Cytotoxic T Lymphocytes That Recognize Naturally Processed Peptides on Human Melanoma Cells

Immunological Characterization of Hodgkin's and Non-Hodgkin's Lymphoma Patients with High Antibody Titers against Epstein-Barr Virus-associated Antigens

Cell-mediated Immune Reactions in Three Patients with Malignant Lymphoproliferative Diseases in Remission and Abnormally High Epstein-Barr Virus Antibody Titers

Email alerts

AACR Journals

Abstract CT032: Adoptive T cell transfer combined with DC vaccination in patients with metastatic melanoma

Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms

A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins

Frequent Loss of HLA-A2 Expression in Metastasizing Ovarian Carcinomas Associated with Genomic Haplotype Loss and HLA-A2-Restricted HER-2/neu-Specific Immunity

Synthetic Peptides Derived from the Melanocyte-stimulating Hormone Receptor MC1R Can Stimulate HLA-A2-restricted Cytotoxic T Lymphocytes That Recognize Naturally Processed Peptides on Human Melanoma Cells

Immunological Characterization of Hodgkin's and Non-Hodgkin's Lymphoma Patients with High Antibody Titers against Epstein-Barr Virus-associated Antigens

Cell-mediated Immune Reactions in Three Patients with Malignant Lymphoproliferative Diseases in Remission and Abnormally High Epstein-Barr Virus Antibody Titers

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Melanoma-Educated CD14⁺ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms